Correction: Osteopenia in children with cerebral palsy can be treated with oral alendronate (Child's Nervous System, (2012), 28, 2, (283-286), 10.1007/s00381-011-1576-9);Osteopenia in children with cerebral palsy can be treated with oral alendronate

Child's Nervous System

Volumn 28, Issue 2, 2012, Pages 283-286

  Paksu, Muhammet Sukru ^a,c   Vurucu, Sebahattin ^b   Karaoglu, Abdulbaki ^b   Karacalioglu, Alper Ozgur ^b   Polat, Ahmet ^b   Yesilyurt, Ozgur ^b   Unay, Bulent ^b   Akin, Ridvan ^b  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Biphosphonate; Cerebral palsy; Child; Osteopenia

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; PHOSPHATE;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; BONE DENSITY; CALCIUM BLOOD LEVEL; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; HYPOCALCEMIA; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LIVER DISEASE; LIVER FUNCTION TEST; MALE; OSTEOPENIA; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUADRIPLEGIC CEREBRAL PALSY; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 84856752694     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-023-05890-8     Document Type: Erratum

References (32)

1. T Akcay S Turan T Guran A Bereket 2008 Alendronate treatment in children with osteogenesis imperfecta Indian Pediatr 45 105 109 18310788 (Pubitemid 351340727)
2. O Ali M Shim E Fowler M Greenberg D Perkins W Oppenheim P Cohen 2007 Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study J Clin Endocrinol Metab 92 932 937 17179200 10.1210/jc.2006-0385 1:CAS:528:DC%2BD2sXjtlGnu7s%3D (Pubitemid 46465665)
3. N Allington D Vivegnis P Gerard 2005 Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study Acta Orthop Belg 71 91 97 15792214 (Pubitemid 40349330)
4. GI Baroncelli S Bertelloni F Sodini G Saggese 2005 Osteoporosis in children and adolescents: etiology and management Paediatr Drugs 7 295 323 16220996 10.2165/00148581-200507050-00003 (Pubitemid 41455886)
5. SL Bass G Naughton L Saxon S Iuliano-Burns R Daly EM Briganti C Hume C Nowson 2007 Exercise and calcium combined results in a greater osteogenic effect than either factor alone: a blinded randomized placebo-controlled trial in boys J Bone Miner Res 22 458 464 17181396 10.1359/jbmr.061201 1:CAS:528: DC%2BD2sXmslKgtrk%3D (Pubitemid 46797129)
6. ML Bianchi 2007 Osteoporosis in children and adolescents Bone 41 486 495 17706477 10.1016/j.bone.2007.07.008 (Pubitemid 47386052)
7. JM Caulton KA Ward CW Alsop G Dunn JE Adams MZ Mughal 2004 A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy Arch Dis Child 89 131 135 14736627 10.1136/adc.2002.009316 1:STN:280:DC%2BD2c%2Fjs1yrug%3D%3D (Pubitemid 38168971)
8. KE Chad DA Bailey HA McKay GA Zello RE Snyder 1999 The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy J Pediatr 135 115 117 10393617 10.1016/S0022-3476(99)70340-9 1:STN:280:DyaK1Mzit1Snuw%3D%3D (Pubitemid 30180575)
9. Conwell LS, Chang AB (2009) Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev (4):CD002010
10. E Demir A Bereket B Ozkan M Topcu 2000 Effect of alendronate treatment on the clinical picture and bone turnover markers in chronic idiopathic hyperphosphatasia J Pediatr Endocrinol Metab 13 217 221 10711670 10.1515/JPEM.2000.13.2.217 1:STN:280:DC%2BD3c7nsVyisA%3D%3D (Pubitemid 30117220)
11. FH Glorieux NJ Bishop H Plotkin G Chabot G Lanoue R Travers 1998 Cyclic administration of pamidronate in children with severe osteogenesis imperfecta N Engl J Med 339 14 947 952 9753709 10.1056/NEJM199810013391402 1:CAS:528:DyaK1cXmslCitrk%3D (Pubitemid 28455096)
12. D Goksen S Darcan M Coker T Kose 2006 Bone mineral density of healthy Turkish children and adolescents J Clin Densitom 9 84 90 16731436 10.1016/j.jocd.2005.08.001 (Pubitemid 44218614)
13. RC Henderson JA Kairalla JW Barrington A Abbas RD Stevenson 2005 Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy J Pediatr 146 769 775 15973316 10.1016/j.jpeds.2005.02. 024 (Pubitemid 40840597)
14. RC Henderson RK Lark MJ Gurka G Worley EB Fung M Conaway VA Stallings RD Stevenson 2002 Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy Pediatrics 110 1 Pt 1 e5 12093986 10.1542/peds.110.1.e5
15. RC Henderson RK Lark HH Kecskemethy F Miller HT Harcke SJ Bachrach 2002 Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial J Pediatr 141 644 651 12410192 10.1067/mpd.2002.128207 1:CAS:528:DC%2BD38XptlCntrc%3D (Pubitemid 35292762)
16. CM Houlihan RD Stevenson 2009 Bone density in cerebral palsy Phys Med Rehabil Clin N Am 20 493 508 19643349 10.1016/j.pmr.2009.04.004
17. Y Inoue N Shimojo S Suzuki T Arima M Tomiita M Minagawa Y Kohno 2008 Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases Clin Rheumatol 27 909 912 18330609 10.1007/s10067-008-0864-6
18. T Iwasaki K Takei S Nakamura N Hosoda Y Yokota M Ishii 2008 Secondary osteoporosis in long-term bedridden patients with cerebral palsy Pediatr Int 50 269 275 18533934 10.1111/j.1442-200X.2008.02571.x (Pubitemid 351781495)
19. P Kilpinen-Loisa H Nenonen H Pihko O Makitie 2007 High-dose vitamin D supplementation in children with cerebral palsy or neuromuscular disorder Neuropediatrics 38 167 172 18058622 10.1055/s-2007-990266 1:CAS:528: DC%2BD1cXhs1yqtrs%3D
20. S Kitazaki K Mitsuyama J Masuda K Harada H Yamasaki K Kuwaki H Takedatsu G Sugiyama O Tsuruta M Sata 2009 Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis Aliment Pharmacol Ther 29 424 430 19035979 10.1111/j.1365-2036.2008.03899.x 1:CAS:528:DC%2BD1MXivVGrsbo%3D
21. JJ Lee ED Lyne 1990 Pathologic fractures in severely handicapped children and young adults J Pediatr Orthop 10 497 500 2358490 1:STN:280: DyaK3c3ptlWgsQ%3D%3D (Pubitemid 20315716)
22. A Noguera JB Ros C Pavia E Alcover C Valls M Villaronga E Gonzalez 2003 Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children J Pediatr Endocrinol Metab 16 529 536 12793604 10.1515/JPEM.2003.16.4. 529 1:CAS:528:DC%2BD3sXlt1yqurw%3D (Pubitemid 37259141)
23. R Palisano P Rosenbaum S Walter D Russell E Wood B Galuppi 1997 Development and reliability of a system to classify gross motor function in children with cerebral palsy Dev Med Child Neurol 39 214 223 9183258 10.1111/j.1469-8749.1997.tb07414.x 1:STN:280:DyaK2szis1CgtQ%3D%3D (Pubitemid 27226331)
24. Phillipi CA, Remmington T, Steiner RD (2008) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev (4):CD005088
25. H Plotkin S Coughlin R Kreikemeier K Heldt M Bruzoni G Lerner 2006 Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study Dev Med Child Neurol 48 709 712 16904014 10.1017/ S0012162206001526 (Pubitemid 44227159)
26. RR Recker EM Lewiecki PD Miller J Reiffel 2009 Safety of bisphosphonates in the treatment of osteoporosis Am J Med 122 2 Suppl 22 32 10.1016/j.amjmed. 2008.12.004
27. S Salehpour S Tavakkoli 2010 Cyclic pamidronate therapy in children with osteogenesis imperfecta J Pediatr Endocrinol Metab 23 73 80 20432809 10.1515/JPEM.2010.23.1-2.73 1:STN:280:DC%2BC3czgtlOjtw%3D%3D
28. NJ Shaw CP White WD Fraser L Rosenbloom 1994 Osteopenia in cerebral palsy Arch Dis Child 71 235 238 7979497 10.1136/adc.71.3.235 1:STN:280: DyaK2M%2FntValtQ%3D%3D (Pubitemid 24298270)
29. T Sugiyama T Takaki T Saito T Taguchi 2007 Vitamin K therapy for cortical bone fragility caused by reduced mechanical loading in a child with hemiplegia J Musculoskelet Neuronal Interact 7 219 223 17947803 1:CAS:528: DC%2BD1cXhsVOrsb4%3D (Pubitemid 350238148)
30. HA Tasdemir M Buyukavci F Akcay P Polat A Yildiran C Karakelleoglu 2001 Bone mineral density in children with cerebral palsy Pediatr Int 43 157 160 11285068 10.1046/j.1442-200x.2001.01352.x 1:STN:280:DC%2BD3MvgvFGrtg%3D%3D (Pubitemid 32378525)
31. E Unal A Abaci E Bober A Buyukgebiz 2006 Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis J Pediatr Endocrinol Metab 19 523 528 16759038 1:CAS:528:DC%2BD28XlvFyqtr8%3D (Pubitemid 43772796)
32. B Unay SU Sarici S Vurucu N Inanc R Akin E Gokcay 2003 Evaluation of bone mineral density in children with cerebral palsy Turk J Pediatr 45 11 14 12718364 (Pubitemid 36347945)